Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Organon & Co. Director's Dealing 2021

Aug 9, 2021

31461_dirs_2021-08-09_afa1eef7-f2b7-4dd9-8cee-a37d67b1c15c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2021-08-05

Reporting Person: Telman Deborah H (EVP GC & Corporate Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-05 Common Stock M 6445 $28.63 Acquired 6445 Direct
2021-08-05 Common Stock F 1889 $28.63 Disposed 4556 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-08-05 Restricted Stock Units $ M 6445 Acquired 2023-08-05 Common Stock (6445) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Organon & Co. ("Organon") common stock.

F2: These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments on August 5, 2021, August 5, 2022 and August 5, 2023.